Showing results (261-270 of 280) with videos related to
Sort By:
Pageof 28
JCO Oncology Practice|May 2, 2025
Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate CancerSigrid V Carlsson, Pedro C Barata, Alan H Bryce, et al.Urologic Oncology|November 5, 2024
Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meetingStephanie A Berg, Salvatore La Rosa, Tian Zhang, et al.Cancer|March 25, 2021
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)Michael R Harrison, Brian A Costello, Nrupen A Bhavsar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2019
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY StudyAndrew J Armstrong, Susan Halabi, Jun Luo, et al.JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.JCO Global Oncology|November 4, 2022
IRONMAN: A Novel International Registry of Men With Advanced Prostate CancerLorelei A Mucci, Jacob Vinson, Theresa Gold, et al.Cancer Research Communications|December 18, 2023
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United StatesEmily M Rencsok, Natalie Slopen, Hannah D McManus, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2020
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyMerry Jennifer Markham, Kerri Wachter, Neeraj Agarwal, et al.Oncoimmunology|September 14, 2020
Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patientsTian Zhang, Sarabjot Pabla, Felicia L Lenzo, et al.European Urology Open Science|December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyKaren A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.Pageof 28